Notice: Our website will be down for maintenance from June 13 - June 14.

CSL Behring Presents Phase 3 Data about Afstyla for Hemophilia A

Note: The below is an edited version of an article originally published on PR Newswire. The original release can be read in it’s entirety here.CSL Behring today presented data from a Phase III pivotal study of Afstyla [Antihemophilic Factor (Recombinant), Single Chain] in hemophilia A patients less than 12 years of age at the XXXII International Congress of […]

en_USEnglish